Company Filing History:
Years Active: 2015
Title: **Frank Coumans: Innovator in Rare Event Analysis**
Introduction
Frank Coumans is an accomplished inventor based in Stein, Netherlands, with a keen focus on innovations in the field of biological analysis. He holds a patent that showcases his dedication to advancing diagnostic methodologies, particularly in the analysis of rare biological events.
Latest Patents
Coumans is credited with a patent titled "High sensitivity multiparameter method for rare event analysis in a biological sample." This invention involves a method for identifying and analyzing rare circulating tumor cells (CTCs) and other significant cells in blood samples. By utilizing fluorescent markers for imaging, his technique allows for the precise tracking of target cells within the sample. This method not only identifies these cells but also enables further interrogation through photobleaching and additional biomarker analysis. The invention has potential applications in various areas, including oncology and immunology, enhancing the understanding of complex biological systems.
Career Highlights
Frank Coumans is currently associated with Janssen Diagnostics, LLC, where he applies his innovative skills to enhance diagnostic testing. His work is pivotal in improving the detection and analysis of critical health markers, ultimately contributing to better patient outcomes. Coumans has demonstrated a strong commitment to advancing medical diagnostics through his technological contributions.
Collaborations
During his career, Coumans has collaborated with notable colleagues, including Mark Carle Connelly and Steve Gross. These collaborations highlight the teamwork involved in his innovative projects and underscore the interdisciplinary approach needed to tackle complex biological questions through technological advancements.
Conclusion
Frank Coumans stands out as a significant figure in the field of diagnostics, with his contributions leading to advancements in the analysis of rare biological events. His patented methods provide new insights into cellular analysis, positioning him as a key innovator within the biosciences sector. As technology continues to evolve, the impact of his work will likely inspire future research and innovations in medical diagnostics.